Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening
Creators
- Posso, Margarita1, 2
- Louro, Javier1, 2
- Román, Marta1, 2
- Sala, María1, 2
- Alcántara, Rodrigo3
- Vázquez, Ivonne4
- Comerma, Laura4
- Baré, Marisa5, 1
- Quintana, M. Jesús6, 7
- Marcos-Gragera, Rafael8, 9, 6
- Vernet-Tomas, María10
- Saladie, Francina11
- Vidal, Carmen12
- Bargalló, Xavier13
- Peñalva, Lupe14
- Castells, Xavier15, 1, 2
- The BELE study group
- 1. Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona (Spain)
- 2. Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona (Spain)
- 3. Department of Radiology, Hospital del Mar, Barcelona (Spain)
- 4. Pathology Department, Hospital del Mar, Parc de Salut Mar, Barcelona (Spain)
- 5. Cancer Screening and Epidemiology, Parc Taulí University Hospital-UAB, Sabadell (Spain)
- 6. CIBER of Epidemiology and Public Health (CIBERESP), Barcelona (Spain)
- 7. Department of Clinical Epidemiology and Public Health, University Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona (Spain)
- 8. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Salt (Spain)
- 9. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona (Spain)
- 10. Department of Obstetrics and Gynecology, IMIM (Hospital del Mar Medical Research Institute), Barcelona (Spain)
- 11. Epidemiology and Cancer Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV, Reus (Spain)
- 12. Cancer Prevention and Control Program, Catalan Institute of Oncology, Barcelona (Spain)
- 13. Department of Radiology, Hospital Clinic, Barcelona (Spain)
- 14. Vallés Oriental Breast Cancer Early Detection Program, Barcelona (Spain)
- 15. Universitat Autònoma de Barcelona, Barcelona (Spain)
Description
To evaluate the mammographic features in women with benign breast disease (BBD) and the risk of subsequent breast cancer according to their mammographic findings. We analyzed data from a Spanish cohort of women screened from 1995 to 2015 and followed up until December 2017 (median follow-up, 5.9 years). We included 10,650 women who had both histologically confirmed BBD and mammographic findings. We evaluated proliferative and nonproliferative BBD subtypes, and their mammographic features: architectural distortion, asymmetries, calcifications, masses, and multiple findings. The adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for breast cancer were estimated using a Cox proportional hazards model. We plotted the adjusted cumulative incidence curves. Calcifications were more frequent in proliferative disease with atypia (43.9%) than without atypia (36.8%) or nonproliferative disease (22.2%; p value < 0.05). Masses were more frequent in nonproliferative lesions (59.1%) than in proliferative lesions without atypia (35.1%) or with atypia (30.0%; p value < 0.05). Multiple findings and architectural distortion were more likely in proliferative disease (16.1% and 4.7%) than in nonproliferative disease (12.8% and 1.9%). Subsequent breast cancer occurred in 268 (2.5%) women. Compared with women who had masses, the highest risk of subsequent breast cancer was found in those with architectural distortions (aHR, 2.21; 95% CI, 1.16-4.22), followed by those with multiple findings (aHR, 1.89; 95% CI, 1.34-2.66), asymmetries (aHR, 1.66; 95% CI, 0.84-3.28), and calcifications (aHR, 1.60; 95% CI, 1.21-2.12). BBD subtypes showed distinct mammographic findings. The risk of subsequent breast cancer was high in those who have shown architectural distortion, multiple findings, asymmetries, and calcifications than in women with masses. The presence of mammographic findings in women attending breast cancer screening helps clinicians to assess women with benign breast disease (BBD). Calcifications were frequent in BBDs with atypia, which are the ones with a high breast cancer risk, while masses were common in low-risk BBDs. The excess risk of subsequent breast cancer in women with BBD was higher in those who showed architectural distortion compared to those with masses.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00330-021-08118-yAdditional details
Identifiers
Publishing Information
- Journal Title
- European Radiology (Internet)
- Journal Volume
- 32
- Journal Issue
- 1
- Journal Page Range
- p. 621-629
- ISSN
- 1432-1084
- CODEN
- EURAE3
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 53030281
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOMEDICAL RADIOGRAPHY; CARCINOMAS; CELL PROLIFERATION; DATA COMPILATION; DELAYED RADIATION EFFECTS; HEALTH HAZARDS; HISTOLOGY; MAMMARY GLANDS; SCREENING; SPAIN; TUMOR CELLS; WOMEN
- Descriptors DEC
- ANIMAL CELLS; ANIMALS; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; DATA; DATA PROCESSING; DEVELOPING COUNTRIES; DIAGNOSTIC TECHNIQUES; DISEASES; EUROPE; FEMALES; GLANDS; HAZARDS; HUMANS; INFORMATION; MAMMALS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; PRIMATES; PROCESSING; RADIATION EFFECTS; RADIOLOGY; VERTEBRATES; WESTERN EUROPE
Optional Information
- Collaborations
- The BELE study group